SEATTLE–(BUSINESS WIRE)–#TissueBanking–According to Coherent Market Insights, the global tissue banking market
was valued at US$ 1.04 billion in 2017, and is projected to exhibit a
CAGR of 10.8% over the forecast period (2018–2026).
Key Trends and Analysis of the Tissue Banking Market:
Companies in global tissue banking market are proactively working
towards the research and development to explore new opportunities. In
October 2018, MTF Biologics announced the formation of a new tissue
recovery relationship with Regenerative Biologics, Inc. The
organizations will seek to provide expanded birth-tissue donation
opportunities to expectant mothers and their families and enhance
patients’ access to high-quality placental tissues for wound care
applications.
Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2600
Furthermore, in 2017, Natera, announced the launch of Evercord, a new
offering that enables expectant parents to collect, store, and
potentially retrieve their newborn’s cord, blood, and tissue for
therapeutic use in transplantation and regenerative medicine
applications. The company will offer Evercord through direct sales
channel in the U.S.
Furthermore, in 2017, Americord expanded customer options by offering
placental tissue banking as a stand-alone service, thereby eliminating
the requirement to bank umbilical cord blood.
To know the latest trends and insights prevalent in this market,
click the link below:
https://www.coherentmarketinsights.com/market-insight/tissue-banking-market-2600
Key Market Takeaways:
-
The global tissue banking market is expected to exhibit a CAGR of
10.8% during the forecast period (2018–2026), attributed to rising
demand for transplantation. According to the University of Texas
Southwestern Medical Center 2018 report, around 450,000 Americans
underwent tissue transplants to improve or save their lives and around
45,000 corneal transplants were done to restore sight. As per the same
source, over 300,000 bone grafts were expected to be used in the
treatment of degenerative bone diseases, malignancies, and traumatic
injuries. -
Asia Pacific tissue banking market is expected to grow at the highest
CAGR during the forecast period, owing to initiatives taken by
government to fulfil rising demand and supply gap for tissue banking.
For instance, in 2017, National Biomaterial Centre (National Tissue
Bank), was inaugurated at New Delhi, India, which aims to fill the gap
between demand and supply for tissues. The center will also provide
quality assurance in the availability of various tissues. -
Key players operating in the global tissue banking market include AbD
Serotec (a Bio-Rad company), AMS Biotechnology Limited, BioLife
Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage
Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD
Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation,
Hamilton Company, Merck KGaA, PHC Corporation, and Teva Pharmaceutical
Industries Ltd.
Buy this report now @ https://www.coherentmarketinsights.com/insight/buy-now/2600
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting
firm offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contacts
Mr. Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle,
WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com